This Week in Consulting

Wednesday,April 24th, 2019

AI in Life Sciences: The Formula for Pharma Success Across the Drug Lifecycle


“AI has wider potential to cut the costs of the industry’s research and development (R&D) spend, which for the largest 10 pharmaceutical companies is $67 billion (equivalent to 40% of the sector’s total R&D bill).”

Artificial intelligence (AI) has the potential to transform the pharmaceutical industry. Each of the major pharma players is investing in the technology at some level, and there are a growing number of applications that address target and drug discovery, preclinical and clinical development, and post-approval activities. With AI comes the potential to improve drug approval rates, reduce development costs, get medications to patients faster and help patients comply with their treatments..

This Week’s Must Read  features an executive insights from L.E.K. reviews the opportunities that artificial intelligence can bring for pharma companies and four key factors that players should address when developing their AI strategy.

Read on to Find out More: “AI in Life Sciences: The Formula for Pharma Success Across the Drug Lifecycle“, Clay Heskett, Ben Faircloth and Stephen Roper, L.E.K. Consulting.


Receive "This Week in
Consulting" in your

Please complete this form to create an account, receive email updates and much more.
*Required Fields
Note: It is our responsibility to protect your privacy and we guarantee that your email address will be completely confidential.


The fourth industrial revolution is upon us: machines infused with intelligence. This transformation will transform how manufacturing works today, making it 30% faster and 25% cheaper because a machine will know when it makes a mistake and will correct itself.



  • How to Get Pharma Leaders to Wrap Their Minds—and Their Arms—Around Advanced Analytics :The business of pharma is becoming more data-driven—from R&D to commercial—yet many pharma companies still struggle to garner leaders’ buy-in to build and operate the analytics programs that they need to fuel their success. They face tough challenges, including overcoming skepticism, proving the program’s value and scalability, finding the right talent and ensuring organizational collaboration.  | Shreyas Murthi, ZS Associates
  • Biopharma’s New Growth Machine: Three signs indicate biopharma is facing compressive disruption that could threaten traditional approaches. Biopharma companies that embrace New Science are driving exceptional growth and mitigating the disruptive forces of compression. Find out how leaders in New Science are using digital, data and genomics to reshape the biopharma landscape and patient care. | Stuart Henderson, Accenture
  • How can automation improve outpatient care while reducing costs? Healthcare often sees automation as a luxury—very few healthcare organisations are exploiting the benefits that automation has to offer. But as it has the potential to reduce staffing costs and improve quality and efficiency, more organisations should see it as a valuable opportunity during this time of financial challenges.  | Francesca MacVean and Gareth Fitzgerald, PA Consulting
  • Artificial Intelligence in Pharma: Set Your Expectations Appropriately -The question of the progress with applying artificial intelligence in pharma is not solely a digital transformation issue. It’s also a broader innovation issue. Innovation is the result of disciplined experimentation and in most use cases pharmaceutical manufacturers are experimenting with emerging technologies.  | Paul Schrimpf and Tony Fross, Prophet


Consulting Quest wishes to organize a series of webinars with experts, if you are interrested and / or if you wish to make your contribution, please contact us by clicking below. Thank you !

Interested in Submitting?

If you are interested in submitting an article, an event or an ad, contact us at




  • Are you a Consultant with Supply Chain background or prior experience working in Retail/CPG? This may be the opportunity you have been long for. A Client of Consulting Quest – an Asia-based small Global Consulting Firm – is seeking to hire an Engagement Manager to join their newly established office in New York City.  Learn More  

About Consulting Quest

Consulting Quest is a global, performance-driven consulting platform founded in 2014 by former members of top 10 consulting firms with the objective of reinventing consultancy performance. With a worldwide presence and a range of proprietary performance measurement tools, we help companies navigate the consulting maze. We work with Consulting Clients to increase their performance through consulting and Consulting Providers to help them acquire new clients and to improve their performance.

[et_social_follow icon_style=”slide” icon_shape=”circle” icons_location=”top” col_number=”auto” total=”true” outer_color=”dark”]

CEO and Co-Founder at | Website | + posts

Hélène Laffitte is the CEO of Consulting Quest, a Global Performance-Driven Consulting Platform and author of “Smart Consulting Sourcing”, a step by step guide to getting the best ROI from your consulting. With a blend of experience in Procurement and Consulting, Hélène is passionate about helping Companies create more value through Consulting.

Navigating Cloud Trends in 2023: A Year in Review | This Week in Consulting
Navigating Cloud Trends in 2023: A Year in Review | This Week in Consulting
In 'This Week in Consulting,' we dug deep into cloud computing, sharing success stories, industry growth, and real-life cases from different sectors.
Navigating Construction’s Highs and Hurdles| This Week in Consulting
Navigating Construction’s Highs and Hurdles| This Week in Consulting
In this edition of This Week in Consulting, we explore market acrobatics, talent shortages, and the wild ride of integrating new tech.
The Modern Paradigm of Talent Management | This Week in Consulting
The Modern Paradigm of Talent Management | This Week in Consulting
In this edition of This Week in Consulting, we delve into the primary challenges facing the global staffing industry, examining the multifaceted influences—from AI, DEI, and ethics to cloud technologies—that are orchestrating a paradigm shift in the talent landscape.